Delivery Order SPE2DB22D1106-SPE2DB25FFGF1
- Not listed
- The Defense Logistics Agency awarded a $6.38K delivery order to AmerisourceBergen Drug Corp for Menveo A-C-Y-W vaccine kits (2 vials) on September 17, 2025, with completion targeted for September 18, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99M and extending through December 2026. The prime IDC serves as a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $7,087.92 to AmerisourceBergen Drug Corp for Menveo A-C-Y-W Kit (2 vials) on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,289.41 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W Kit (2 Vials) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The Menveo vaccine is a meningococcal conjugate vaccine used for immunization against...
- The Defense Logistics Agency awarded a delivery order valued at $5,677.70 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Menveo A-C-Y-W vaccine kits (2 vials). This is a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a non-competitive award, indicating the product was procured through an existing contract vehicle rather than a new...
- The Defense Logistics Agency awarded a delivery order valued at $1,678.60 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. The contract, executed on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,342.88 to AmerisourceBergen Drug Corp for Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. The contract was awarded on July 28, 2025, with completion targeted for July 29, 2025, and represents a firm fixed-price delivery order with no set-aside designation. Performance will occur at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on February 7, 2025, for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal conjugate vaccine used for immunization against multiple meningococcal serogroups. This competitively awarded, non-set-aside contract has a ceiling value of $1,678.60 with a firm fixed price structure and an ultimate completion date of February 10, 2025. The work will be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $6.8K to AmerisourceBergen Drug Corp for Menveo A-C-Y-W Kit (2 vials) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order represents a routine pharmaceutical procurement executed through competitive procedures without set-aside designation. The award reflects AmerisourceBergen's role as a critical vendor within the federal medical supply chain, with performance to occur at the...
- The Defense Logistics Agency awarded a $1,342.88 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal conjugate vaccine. This firm fixed price, non-set-aside contract is scheduled for completion by September 8, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,035.80 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. This is a firm fixed-price, competitively awarded contract with performance to be completed by August 12, 2025, and fulfillment based in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a single transaction under AmerisourceBergen's existing federal contract...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFGF1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,042.96 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W Kit (2 vials) on September 2, 2025, with an ultimate completion date of September 3, 2025. This competitively awarded contract utilizes firm fixed-price pricing with no set-aside designation. The pharmaceutical distributor will perform this delivery from its corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The Menveo vaccine is a meningococcal conjugate vaccine used to provide immunization protection against meningococcal disease strains A, C, W, and Y. This award exemplifies AmerisourceBergen's critical role as a major pharmaceutical and medical supply vendor for federal healthcare systems, including the Defense Health Agency and U.S. military personnel. The company's extensive contract portfolio with DLA demonstrates its capability to fulfill diverse medical procurement requirements across multiple therapeutic domains, ranging from vaccines and specialty medications to medical devices and supplies, supporting military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 9/2/25 |